Olivia C Leavy
Overview
Explore the profile of Olivia C Leavy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
592
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Daynes E, Evans R, Greening N, Bishop N, Yates T, Lozano-Rojas D, et al.
Eur Respir J
. 2025 Feb;
PMID: 39978856
Objective: Post-COVID syndrome involves prolonged symptoms with multi-system and functional impairment lasting at least 12 weeks after acute COVID-19. We aimed to determine the efficacy of exercise-based rehabilitation interventions, either...
2.
Chin D, Hernandez-Beeftink T, Donoghue L, Guillen-Guio B, Guillen-Uio B, Leavy O, et al.
medRxiv
. 2025 Feb;
PMID: 39974050
Background: Idiopathic pulmonary fibrosis (IPF) is a rare, incurable lung disease with a median survival of 3-5 years after diagnosis. Treatment options are limited. Genetic association studies can identify new...
3.
Moss S, Minelli C, Leavy O, Allen R, Oliver N, Wain L, et al.
Thorax
. 2024 Nov;
80(3):133-139.
PMID: 39613458
Background: Idiopathic pulmonary fibrosis (IPF) is a disease of progressive lung scarring. There is a known association between diabetes mellitus (DM) and IPF, but it is unclear whether a causal...
4.
Tyrer F, Gharibzadeh S, Gillies C, Lawson C, Routen A, Islam N, et al.
Diabetes Obes Metab
. 2024 Nov;
27(2):767-776.
PMID: 39563623
Background: People hospitalised for coronavirus disease 2019 (COVID-19) have elevated incidence of diabetes. However, it is unclear whether this is due to shared risk factors, confounding or stress hyperglycaemia in...
5.
Elneima O, McAuley H, Leavy O, Chalmers J, Horsley A, Ho L, et al.
Int J Epidemiol
. 2024 Oct;
53(1).
PMID: 39429158
No abstract available.
6.
Leavy O, Russell R, Harrison E, Lone N, Kerr S, Docherty A, et al.
ERJ Open Res
. 2024 Oct;
10(5).
PMID: 39351379
Background: In patients with coronavirus disease 2019 (COVID-19) requiring supplemental oxygen, dexamethasone reduces acute severity and improves survival, but longer-term effects are unknown. We hypothesised that systemic corticosteroid administration during...
7.
Taquet M, Skorniewska Z, De Deyn T, Hampshire A, Trender W, Hellyer P, et al.
Lancet Psychiatry
. 2024 Aug;
11(9):696-708.
PMID: 39096931
Background: COVID-19 is known to be associated with increased risks of cognitive and psychiatric outcomes after the acute phase of disease. We aimed to assess whether these symptoms can emerge...
8.
Reddy S, Newman J, Leavy O, Ghani H, Pepke-Zaba J, Cannon J, et al.
Eur Respir J
. 2024 Jul;
64(2.
PMID: 39060016
Background: Pulmonary embolism (PE) is a well-recognised complication of coronavirus disease 2019 (COVID-19) infection, and chronic thromboembolic pulmonary disease with and without pulmonary hypertension (CTEPD/CTEPH) are potential life-limiting consequences. At...
9.
Elneima O, Hurst J, Echevarria C, Quint J, Walker S, Siddiqui S, et al.
ERJ Open Res
. 2024 Jul;
10(4).
PMID: 39010888
Background: The long-term outcomes of COVID-19 hospitalisation in individuals with pre-existing airway diseases are unknown. Methods: Adult participants hospitalised for confirmed or clinically suspected COVID-19 and discharged between 5 March...
10.
Lawson C, Moss A, Arnold J, Bagot C, Banerjee A, Berry C, et al.
Open Heart
. 2024 May;
11(1.
PMID: 38802280
Background: Pre-existing cardiovascular disease (CVD) or cardiovascular risk factors have been associated with an increased risk of complications following hospitalisation with COVID-19, but their impact on the rate of recovery...